Vascular biology of hydrogen sulfide
Author(s) -
Nancy L. Kanagy,
Csaba Szabó,
Andreas Papapetropoulos
Publication year - 2017
Publication title -
ajp cell physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.432
H-Index - 181
eISSN - 1522-1563
pISSN - 0363-6143
DOI - 10.1152/ajpcell.00329.2016
Subject(s) - vasodilation , angiogenesis , context (archaeology) , vascular smooth muscle , neuroscience , microbiology and biotechnology , signal transduction , biology , chemistry , medicine , cancer research , endocrinology , smooth muscle , paleontology
Hydrogen sulfide (H 2 S) is a ubiquitous signaling molecule with important functions in many mammalian organs and systems. Observations in the 1990s ascribed physiological actions to H 2 S in the nervous system, proposing that this gasotransmitter acts as a neuromodulator. Soon after that, the vasodilating properties of H 2 S were demonstrated. In the past decade, H 2 S was shown to exert a multitude of physiological effects in the vessel wall. H 2 S is produced by vascular cells and exhibits antioxidant, antiapoptotic, anti-inflammatory, and vasoactive properties. In this concise review, we have focused on the impact of H 2 S on vascular structure and function with an emphasis on angiogenesis, vascular tone, vascular permeability and atherosclerosis. H 2 S reduces arterial blood pressure, limits atheromatous plaque formation, and promotes vascularization of ischemic tissues. Although the beneficial properties of H 2 S are well established, mechanistic insights into the molecular pathways implicated in disease prevention and treatment remain largely unexplored. Unraveling the targets and downstream effectors of H 2 S in the vessel wall in the context of disease will aid in translation of preclinical observations. In addition, acute regulation of H 2 S production is still poorly understood and additional work delineating the pathways regulating the enzymes that produce H 2 S will allow pharmacological manipulation of this pathway. As the field continues to grow, we expect that H 2 S-related compounds will find their way into clinical trials for diseases affecting the blood vessels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom